Drug recall · January 8, 2025
Atropine Sulfate Ophthalmic Solution recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01
- Lots / codes
Lot #: A240211, Exp. Date April 2026
- Quantity
- 5,870 bottles
- Company
- Somerset Therapeutics LLC, Somerset, NJ
- Distribution
- Nationwide within the United States
- Initiated
- December 16, 2024 · Voluntary: Firm initiated
- Classified
- December 31, 2024
- Reported
- January 8, 2025
- Ended
- June 10, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.